Affinivax Inc

Affinivax, Inc. operates as a clinical stage biopharmaceutical company. The Company develops next generation vaccine technology platform called the Multiple Antigen Presentation System to achieve high-affinity binding of polysaccharide and protein antigens immunogenic components.